Terug
Dagbereik
€ 6,63
€ 7,07
52-Weeksbereik
€ 2,41
€ 8,72
Volume
760.162
50D / 200D Gem.
€ 6,41
/
€ 5,73
Vorige Slotkoers
€ 7,14
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -3,0 | 0,3 |
| P/B | 2,9 | 2,9 |
| ROE % | -109,9 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 12,50
+87.1%
Low: € 9,00
High: € 16,00
Forward WPA
-€ 1,73
Omzet Sch.
3,7 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,17
€ 1,17 – € 1,17
|
460 M | 2 |
| FY2029 |
€ 0,15
€ 0,15 – € 0,15
|
280 M | 4 |
| FY2028 |
-€ 0,96
-€ 1,48 – -€ 0,39
|
110 M | 6 |
Belangrijkste Punten
Debt/Equity of 0,12 — conservative balance sheet
Negative free cash flow of -157,44M
PEG of 0,08 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-109,90%
ROIC-66,81%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,12
Current Ratio6,14
Interest Coverage0,00
Waardering
P/E Ratio
-2,99
P/B Ratio2,89
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -174,33M |
| ROE | -109,90% | ROA | -74,97% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -157,44M |
| ROIC | -66,81% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 6,14 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -2,99 | P/B Ratio | 2,89 |
| P/S Ratio | N/A | PEG Ratio | 0,08 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 520,44M | Enterprise Value | 481,70M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 8,09M | 13,62M |
| Net Income | -174,33M | -124,70M | -96,02M | -85,98M | -72,19M |
| EPS (Diluted) | -1,99 | -3,06 | -4,83 | -10,10 | -10,14 |
| Gross Profit | -1,64M | -2,46M | -2,58M | 8,09M | 13,62M |
| Operating Income | -179,21M | -129,73M | -104,32M | -106,45M | -72,25M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 232,54M | 188,66M | 164,94M | 260,25M | 232,38M |
| Total Liabilities | 52,53M | 51,42M | 38,46M | 48,59M | 24,17M |
| Shareholders' Equity | 180,01M | 137,25M | 126,48M | 211,67M | 208,21M |
| Total Debt | 21,16M | 24,18M | 26,27M | 28,55M | 2,06M |
| Cash & Equivalents | 59,90M | 80,24M | 74,02M | 155,38M | 119,14M |
| Current Assets | 205,46M | 157,30M | 129,73M | 219,64M | 222,61M |
| Current Liabilities | 33,47M | 30,26M | 14,52M | 22,51M | 23,60M |